DANIELLE DECUBELLIS: Open Payments
NPI 1023593142 · NOKOMIS, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,422 in 59 payments from 17 companies in 2025. Trend: 2023 $733 · 2024 $1,466 · 2025 $1,422
Food & beverage: $1,417Education: $5
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 7 | $182 |
| ABBVIE INC. | 11 | $154 |
| Lilly USA, LLC | 6 | $154 |
| Janssen Scientific Affairs, LLC | 1 | $149 |
| Janssen Biotech, Inc. | 7 | $128 |
| GENZYME CORPORATION | 3 | $119 |
| Novartis Pharmaceuticals Corporation | 4 | $91 |
| PFIZER INC. | 3 | $82 |
| LEO Pharma Inc. | 3 | $74 |
| Galderma Laboratories, L.P. | 4 | $72 |
Products named: DUPIXENT, TREMFYA, TALTZ, SKYRIZI, COSENTYX, CIBINQO, ADBRY, NEMLUVIO.
Industry payments across FL — which companies pay providers there.
